Osteoclasts (OCs) are multinucleated giant cells with the function of bone resorption. Multinucleated giant cells are formed by the fusion of mononuclear macrophages differentiated from myeloid hematopoietic stem cells. And osteoclasts play an important role in the development and formation of the bone skeleton, in synergy with osteoblasts.
Early immature proliferative mononuclear phagocytic cells, also called osteoclast precursors, enter the blood circulation under the action of chemical factors and then enter the bone structure cavity under the action of signal factors released by basal multicellular units. Under the stimulation of various chemical factors, transcription factors, cytokines, and other signaling factors, they are fused into multinucleated cells and finally activated into osteoclasts. This process is called osteoclast differentiation.
M-CSF is a key player in promoting the proliferation and survival of osteoclast precursor cells. M-CSF binds to and phosphorylates c-Fms. c-Fms phosphorylation activates itself and then recruits some downstream targets such as phosphatidylinositol 3-kinase (PI3K), Akt, ERK, and Grb2, triggering the ERK and PI3K/Akt pathways that enhance osteoclast precursor cells proliferation and survival.
With the aid of M-CSF, osteoclast precursor cells express RANK (receptor activator of NF-kappa B), which binds to RANKL. RANKL-RANK recruits TRAFs (tumor necrosis factor receptor-associated factors) to the RANK' cytoplasmic region, where TRAKs (TRAF1, TRAF2, TRAF3, TRAF5, and TRAF6) binds to RANK. Among TRAFs, TRAF6 is the most important for osteoclast formation. TRAF6 binds to RANK, initiating and transmitting the differentiation signal of osteoclasts through the JNK (c-Jun N-terminal kinase) pathway, NF-Kappa B pathway, and Akt pathway. TRAF2 and TRAF5 link to RANK, which activates c-Jun N-terminal kinase (JNK). JNK induces c-Jun/Fos-activated protein 1 activation, which regulates c-Fos expression, promoting proliferation and differentiation of osteoclast precursors. TRAF6 binds to RANK to activate phosphatidylinositol-3-kinase (PI-3K), which in turn activates protein kinase B (PKB), Akt, and NF-Kappa B, increasing c-Fos expression. c-Fos combines with the nuclear factor of activated T cells (NFATc1), initiating transcription of osteoclast-specific genes and inducing osteoclast precursor differentiation into mature osteoclasts. Except for the self-regulatory mechanism, elevated bone resorption and blood calcium levels induced by osteoclast maturation and activation also play a regulatory role in the pathway loop. Activation of calcium signaling also stimulates NFATc1 expression.
OPG (osteoprotegerin) exerts its role in the form of osteoblast/stromal cell paracrine secretion. OPG competitively binds to OPGL (or RANKL), which blocks OPGL binding to RANK. The combination between OPG and OPGL inhibits RANKL/RANK pathway, repressing osteoclast differentiation and maturation and prevent osteoclast cells from excessively growing. Besides, OPG can also bind to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and inhibit TRAIL-induced apoptosis.
The RANKL/OPG ratio is related to the strength of osteoclast differentiation. If the ratio decreases, the RANKL on the surface of osteoblasts is all competitively bound by OPG, rather than binding to RANK on the osteoclast precursor, inhibiting differentiation of osteoclasts. If the ratio excessively increases, OPG is difficult to antagonize the binding of RANKL and RANK, resulting in increased osteoclastogenesis and enhanced bone resorption capacity. Therefore, keeping the RANKL/OPG ratio at a certain range is important for maintaining osteoclast differentiation and bone metabolism balance.
|ACP5||ACP5 Antibody||ACP5 Protein||ACP5 cDNA||ACP5 ELISA Kit|
|AKT1||AKT1 Antibody||AKT1 Protein||AKT1 cDNA||AKT1 ELISA Kit|
|AKT2||AKT2 Antibody||AKT2 Protein||AKT2 cDNA||AKT2 ELISA Kit|
|AKT3||AKT3 Antibody||AKT3 Protein||AKT3 cDNA||AKT3 ELISA Kit|
|BLNK||BLNK Antibody||BLNK Protein||BLNK cDNA||BLNK ELISA Kit|
|BTK||BTK Antibody||BTK Protein||BTK cDNA||BTK ELISA Kit|
|CALCR||CALCR Antibody||CALCR Protein||CALCR cDNA||CALCR ELISA Kit|
|CAMK4||CAMK4 Antibody||CAMK4 Protein||CAMK4 cDNA||CAMK4 ELISA Kit|
|CHUK||CHUK Antibody||CHUK Protein||CHUK cDNA||CHUK ELISA Kit|
|CREB1||CREB1 Antibody||CREB1 Protein||CREB1 cDNA||CREB1 ELISA Kit|
|CSF1||CSF1 Antibody||CSF1 Protein||CSF1 cDNA||CSF1 ELISA Kit|
|CSF1R||CSF1R Antibody||CSF1R Protein||CSF1R cDNA||CSF1R ELISA Kit|
|CTSK||CTSK Antibody||CTSK Protein||CTSK cDNA||CTSK ELISA Kit|
|CYBA||CYBA Antibody||CYBA Protein||CYBA cDNA||CYBA ELISA Kit|
|CYLD||CYLD Antibody||CYLD Protein||CYLD cDNA||CYLD ELISA Kit|
|FCGR1A||FCGR1A Antibody||FCGR1A Protein||FCGR1A cDNA||FCGR1A ELISA Kit|
|FCGR2A||FCGR2A Antibody||FCGR2A Protein||FCGR2A cDNA||FCGR2A ELISA Kit|
|FCGR2B||FCGR2B Antibody||FCGR2B Protein||FCGR2B cDNA||FCGR2B ELISA Kit|
|FCGR2C||FCGR2C Antibody||FCGR2C Protein||FCGR2C cDNA||FCGR2C ELISA Kit|
|FCGR3A||FCGR3A Antibody||FCGR3A Protein||FCGR3A cDNA||FCGR3A ELISA Kit|